Compare XERS & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XERS | SVC |
|---|---|---|
| Founded | 2005 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 2021 | 1995 |
| Metric | XERS | SVC |
|---|---|---|
| Price | $8.59 | $8.63 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $10.83 | $2.50 |
| AVG Volume (30 Days) | 2.3M | ★ 9.2M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.67% |
| EPS Growth | ★ 100.00 | 26.95 |
| EPS | ★ 0.01 | N/A |
| Revenue | $49,590,000.00 | ★ $1,814,838,000.00 |
| Revenue This Year | $34.37 | N/A |
| Revenue Next Year | $22.86 | $1.39 |
| P/E Ratio | $883.00 | ★ N/A |
| Revenue Growth | ★ 142.67 | N/A |
| 52 Week Low | $4.87 | $1.13 |
| 52 Week High | $10.08 | $8.92 |
| Indicator | XERS | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 78.63 | 96.41 |
| Support Level | $6.86 | $1.62 |
| Resistance Level | $10.08 | N/A |
| Average True Range (ATR) | 0.32 | 0.11 |
| MACD | 0.13 | 0.70 |
| Stochastic Oscillator | 80.98 | 96.11 |
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.